Skip to main content
. Author manuscript; available in PMC: 2024 Jul 23.
Published in final edited form as: FASEB J. 2023 Mar;37(3):e22825. doi: 10.1096/fj.202201972RR

FIGURE 2.

FIGURE 2

Elevated plasma NAMPT and cytokine in human subjects with NAFLD. (A) Comparison of plasma eNAMPT levels in NAFLD patients (n = 67) and healthy controls (n = 78) showed significantly higher eNAMPT in NAFLD patients (p < .05). NAFLD subjects were grouped into surviving subjects and non-survivors and showed both groups have significantly higher levels of eNAMPT compared to healthy controls, although there were no significant differences between survivors and non-survivors. (B) Comparison of plasma IL-6 levels in NAFLD patients, surviving NAFLD subjects, non-surviving NAFLD subjects, and healthy controls (p < .05). (C) Comparison of plasma IL-1RA levels in NAFLD patients, surviving NAFLD subjects, non-surviving NAFLD subjects, and healthy controls (p < .05). (D) Comparison of plasma ANG2 levels in NAFLD patients, surviving NAFLD subjects, non-surviving NAFLD subjects, and healthy controls (p < .05).